Cardinal Health's stock rises in range of a record after upbeat profit outlook
Shares of Cardinal Health Inc. (CAH) rallied 1.7% in premarket trading Tuesday, after the drug distributor said it expects fiscal 2024 earnings to be at the high-end of previous guidance. The stock was on track to open at the highest price seen since it closed at a record $108.05 on Dec. 13. The company added that while a review of its businesses remains "active and ongoing," it has already determined that it would further develop its growth businesses in its Medical Segment, at-Home Solutions and OptiFreight Logistics businesses. The company had previously guided fiscal 2024 adjusted earnings per share of $6.75 to $7.00, while the current FactSet is $6.96. The stock has run up 15.9% over the past three months through Monday, while the Health Care Select Sector SPDR ETF (XLV) has climbed 7.6% and the S&P 500 has advanced 9.9%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-09-24 0724ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back